Eurofins Viracor will be attending the DDR, ATR & PARP Inhibitors Summit 2022 and excited to participate and have the opportunity to share how our specialized expertise in the oncology sector. We have a seasoned team with decades of experience supporting successful clinical trials, while having the highest quality analytical technology in our state-of-the-art lab to support the most cutting edge science, offering complex bioassay design, optimization, validation and transfer, customized to your study’s needs.

Together with testing performed in our high throughput CAP/CLIA laboratory, we can help advance your study design and clinical trial program. Our experts can offer solutions to minimize risks and keep your program on track, and on time. Registration Open